New approaches to one of the world’s most complex diseases are aiming to give months and years back to those facing an otherwise uncertain future.
Alzheimer’s disease has been a top priority for biopharmaceutical researchers dedicated to discovering new treatments and cures. Current medicines that treat the disease’s cognitive symptoms are just the beginning. To conquer Alzheimer’s, researchers are working to identify and focus on treatments that may ultimately inhibit or halt disease progression.
In the last decade, emerging science has helped Alzheimer’s researchers unravel some of the major complexities of the disease. The more scientists learn, the better they are at developing new treatments aimed at slowing, and even preventing, Alzheimer's entirely. Today, with nearly 100 potential medicines in clinical trials, researchers are more optimistic than ever that a cure will be found well within our lifetime.
stay innovative with us
Innovation is headed to your inbox.
The war against Alzheimer’s might be far from over, but patients finally have hope for the future. And for good reason. With all the emerging advancements coming forward, we now have more promising treatments than ever before. One of which might just defeat this deadly disease entirely. For all of us.